Northwestern Mutual Wealth Management’s Adaptive Biotechnologies ADPT Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio ADPT Stock Details ADPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-4	Closed	-$65	–	4119
2025 Q4	$65	Buy	+4	New	+$65	﹤0.01%	3886
2024 Q4	–	Sell	-24	Closed	-$123	–	3589
2024 Q3	$123	Buy	+24	New	+$105	﹤0.01%	3478
2024 Q1	–	Sell	-270	Closed	-$1.32K	–	3561
2023 Q4	$1.32K	Buy	+270	New	+$1.23K	﹤0.01%	3123
2023 Q3	–	Sell	-90	Closed	-$604	–	3270
2023 Q2	$604	Buy	+90	New	+$669	﹤0.01%	3160

Other funds holding ADPT

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Northwestern Mutual Wealth Management's ADPT Position: Q1 2026 in Review

Northwestern Mutual Wealth Management sold out of Adaptive Biotechnologies (ADPT) in Q1 2026, closing a stake of 4 shares — an estimated $65 sold.

Northwestern Mutual Wealth Management first reported a position in ADPT in Q2 2023 and held it in 4 quarters. The position peaked at $1.32K in Q4 2023. 298 funds tracked by Wall St. Rank hold ADPT as of Q1 2026.

Northwestern Mutual Wealth Management reported no remaining Adaptive Biotechnologies position as of Q1 2026 after selling out during the quarter.
Northwestern Mutual Wealth Management sold 4 Adaptive Biotechnologies shares in Q1 2026, an estimated $65.
Northwestern Mutual Wealth Management first reported a position in Adaptive Biotechnologies in Q2 2023 and held it in 4 quarters.
Northwestern Mutual Wealth Management's Adaptive Biotechnologies position peaked at $1.32K in Q4 2023.
298 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q1 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2026, filed 7 May 2026.